Literature DB >> 12840893

Immunohistochemical study of T lymphocyte subsets on frozen substituted plastic embedding section of the bone marrow from patients with myelodysplastic syndrome and its clinical implication.

S Liu1, X Liu, P Zou, S Song, B Wang.   

Abstract

An immunohistochemical study of T lymphocyte subsets on frozen substituted plastic embedding bone marrow sections obtained from 10 patients with myelodysplastic syndrome (MDS) was presented. The results of qualitative and quantitative immunohistochemical analysis are as follows: (1) Labile antigens of T lymphocytes were well preserved, thus allowing analysis of distribution of T lymphocyte subsets in situ: (2) the average number of T3, T4 and T8 lymphocyte of the diffuse infiltrate was about 2%, 0.4%, 0.5%, respectively, of all nucleated cells in bone marrow, and T4/T8 of T cells were below 1.0 in patients with MDS; (3) there were cases of RAS showing T lymphocyte aggregation in bone marrow, but no patient exhibited progressive refractory anemia with excess of blasts (RAEB) and RAEB in transformation (RAEBT). These findings indicated that the immunological abnormalities are of importance in the evaluation of pathogenesis and prognosis of MDS.

Entities:  

Mesh:

Year:  1999        PMID: 12840893     DOI: 10.1007/bf02887733

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  7 in total

1.  Lymphocyte subsets in normal bone marrow.

Authors:  P Clark; D E Normansell; D J Innes; C E Hess
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

2.  Classification of the myelodysplastic syndromes.

Authors:  J M Bennett
Journal:  Clin Haematol       Date:  1986-11

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Freeze-substitution.

Authors:  D M Harvey
Journal:  J Microsc       Date:  1982-08       Impact factor: 1.758

5.  Myelodysplastic syndromes: a scoring system with prognostic significance.

Authors:  G J Mufti; J R Stevens; D G Oscier; T J Hamblin; D Machin
Journal:  Br J Haematol       Date:  1985-03       Impact factor: 6.998

6.  Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes.

Authors:  J S Kristensen; P Hokland
Journal:  Br J Haematol       Date:  1990-03       Impact factor: 6.998

7.  Immunologic indices in myelodysplastic syndromes.

Authors:  P H Colombat; M Renoux; J P Lamagnere; G Renoux
Journal:  Cancer       Date:  1988-03-15       Impact factor: 6.860

  7 in total
  1 in total

Review 1.  Bone Marrow Immunity and Myelodysplasia.

Authors:  Claude Lambert; Yuenv Wu; Carmen Aanei
Journal:  Front Oncol       Date:  2016-07-20       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.